FDA has approved Alunbrig for ALK-positive metastatic non-small cell lung cancer
The FDA ( Food and Drug Administration ) has approved Alunbrig ( Brigatinib ) for adult patients with anaplastic lymphoma kinase ( ALK )-positive metastatic non-small cell lung cancer ( NSCLC ) as det ...
read article